WeVote
Log In

Bill

MB

Bill

SR 907

Department of Insurance; to meet with stakeholders to explore best practices in the medical surveillance of patients after primary therapy for breast cancer and to provide any recommendations; urge

2025-2026 Regular Session Introduced by Max Burns and 6 co-sponsors

Georgia urges its insurance department to study and recommend best practices for monitoring breast cancer patients after primary treatment to improve post-care standards.

Senate Read and Referred
0
WeVote Research Nonpartisan
Bill Summary · SR 907

Legislative bill overview

SR 907 is a resolution urging Georgia's Department of Insurance to convene stakeholders and study best practices for post-treatment breast cancer surveillance and monitoring. The bill requests the department compile findings and recommendations on medical surveillance protocols after primary breast cancer therapy.

Why is this important

Breast cancer survivors require ongoing monitoring to detect recurrence early, but surveillance standards and insurance coverage policies vary significantly. This resolution aims to establish evidence-based guidelines that could improve patient outcomes and potentially standardize insurance coverage for post-treatment care across the state.

Potential points of contention

  • Regulatory scope: Whether insurance departments have authority to establish clinical surveillance standards traditionally guided by oncology organizations
  • Cost implications: Comprehensive surveillance recommendations could increase insurance claim costs, potentially raising premiums or coverage restrictions
  • Implementation ambiguity: The resolution lacks specifics on timeline, funding, or enforcement mechanisms, making unclear how recommendations would translate into actual policy changes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.